Gross JJ, John OP Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003 Aug;85(2):348-62.
Naragon-Gainey K, DeMarree KG Decentering attentuates the associations of negative affect and positive affect with psychopathology. Clinical Psychological Science. Epub 2017 Aug 11.
Naragon-Gainey K, DeMarree KG Structure and validity of measures of decentering and defusion. Psychol Assess. 2017 Jul;29(7):935-954. doi: 10.1037/pas0000405. Epub 2016 Oct 31.
Shoham A, Goldstein P, Oren R, Spivak D, Bernstein A Decentering in the process of cultivating mindfulness: An experience-sampling study in time and context. J Consult Clin Psychol. 2017 Feb;85(2):123-134. doi: 10.1037/ccp0000154.
Tangney JP, Baumeister RF, Boone AL High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers. 2004 Apr;72(2):271-324.
Watson D, Clark LA, Tellegen A Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.